Pankreas Kitlelerinin Ayırıcı Tanısında Endoskopik Yöntemlerin Yeri
Özet
Pankreas kitlelerinin ayırıcı tanısında kullanılan endoskopik yöntemlerin ele alındığı bu metinde, erken tanının önemi ve teknolojik imkanlar detaylandırılmaktadır. Pankreasın malign neoplazmları dünya genelinde kanser ölümlerinde yedinci sırada yer alırken, duktal adenokarsinomlar vakaların yüzde 85'ini oluşturmaktadır. Cerrahi müdahale tek küratif seçenek olsa da, hastaların yalnızca yüzde 15-20'si tanı anında bu tedaviye uygundur. Bu süreçte Endoskopik Ultrason (EUS), özellikle 2 cm'den küçük kitlelerin tespitinde yüksek duyarlılığa sahip kritik bir modalite olarak öne çıkar. EUS-FNA (ince iğne aspirasyonu) patolojik tanı imkanı sağlarken, kontrastlı EUS ve elastografi gibi yeni yöntemler benign-malign ayrımında ek veriler sunar. Kistik lezyonların değerlendirilmesinde de EUS, kist sıvısı analizi ve mural nodül incelemesi ile yol göstericidir. Diğer yandan, Endoskopik Retrograd Kolanjiopankreatografi (ERCP), invaziv doğası ve gelişen diğer görüntüleme yöntemleri nedeniyle daha çok safra drenajı gibi terapötik amaçlarla kullanılmaktadır; ancak özellikle evre 0 karsinoma in situ tanısında fırçalama sitolojisi ile hala değerini korumaktadır. Sonuç olarak, pankreas lezyonlarının karakterizasyonunda EUS yüksek hassasiyetiyle temel araçtır.
In the differential diagnosis of pancreatic masses, endoscopic methods play a critical role, as emphasized in this text where early detection is vital since only 15-20% of patients are eligible for surgery upon diagnosis. Endoscopic Ultrasound (EUS) stands out with high sensitivity, particularly for identifying tumors smaller than 2 cm, and enables pathological diagnosis through fine-needle aspiration (EUS-FNA), while newer techniques like contrast-enhanced EUS and elastography further assist in distinguishing between benign and malignant lesions. Although Endoscopic Retrograde Cholangiopancreatography (ERCP) is increasingly reserved for therapeutic purposes such as biliary drainage due to its invasive nature, it remains essential for diagnosing early-stage cancers and carcinoma in situ through detailed pancreatic juice cytology. While EUS is the primary tool for high-accuracy characterization of solid and cystic pancreatic lesions, ERCP continues to hold significance for specific early-stage epithelial cases, collectively ensuring a comprehensive diagnostic approach to improve patient outcomes.
Referanslar
GLOCOBAN (2020). Estimated number of deaths in 2020, worldwide, both sexes and ages. (04/12/2021 tarihinde https://gco.iarc.fr/today/online-analysis piev=2020&mode cancer&mode_population continents&population 900&populations 900&key total&sex=0&cancer=9&type=1&statistic 5&prevalence=0&population_group 0&ages_group%5B%5D=0&ages_group%5B%5D 17&nb_items 7&group_cancer 1&include_nmsc 1&include_nmsc_other 1&half_pie=0&donut 0 adresinden ulaşılmıştır.)
Allen PJ, Kuk D, Castillo CF, et al. Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients with Pancreatic Adenocarcinoma. Ann Surg 2017; 265:185.
Klimstra DS. Nonductal neoplasms of the pancreas. Mod Pathol 2007; 20 Suppl 1:S94.
Kitano M, Yoshida T, Itonaga M, et al. Impact of endoscopic ultrasonography on diagnosis of pancreatic cancer. J Gastroenterol. 2019;54:19–32.
Krishna SG, Rao BB, Ugbarugba E, et al. Diagnostic performance of endoscopic ultrasound for detection of pancreatic malignancy following an indeterminate multidetector CT scan: A systemic review and meta-analysis. Surg Endosc. 2017;31:4558–4567.
Yasuda I, Iwashita T, Doi S, et al. Role of Eus in the Early Detection of Small Pancreatic Cancer. Dig. Endosc. 2011;23:22–25.
Mertz HR, Sechopoulos P, Delbeke D, et al. EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma. Gastrointest Endosc 2000;52:367–371.
Soriano A, Castells A, Ayuso C, et al. Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography. Am J Gastroenterol. 2004;99:492–501.
Brand B, Pfaff T, Binmoeller KF, et al. Endoscopic ultrasound for differential diagnosis of focal pancreatic lesions, confirmed by surgery. Scand J Gastroenterol. 2000;35:1221–1228.
Wangermez M. Endoscopic ultrasound of pancreatic tumors. Diagn Interv Imaging. 2016;97:1287-1295.
Voss M, Hammel P, Molas G, et al. Value of endoscopic ultrasound guided fine needle aspiration biopsy in the diagnosis of solid pancreatic masses. Gut. 2000;46:244–249.
Harewood GC, Wiersema MJ. Endosonography-guided fine needle aspiration biopsy in the evaluation of pancreatic masses. Am J Gastroenterol. 2002;97:1386–1391.
Iglesias GJ, Dominguez-Munoz JE. Endoscopic ultrasound-guided biopsy for the evaluation of pancreatic tumors. Gastroenterol Hepatol. 2007;30:597–601.
DeWitt J, McGreevy K, Sherman S, et al. Utility of a repeated EUS at a tertiary-referral center. Gastrointest Endosc. 2008;67:610–619.
Warshaw AL. Implications of peritoneal cytology for staging of early pancreatic cancer. Am J Surg. 1991;161:26–29, discussion 29–30.
Micames C, Jowell PS, White R, et al. Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA. Gastrointest Endosc. 2003;58:690–695.
Varadarajulu S, Tamhane A, Eloubeidi MA. Yield of EUS-guided FNA of pancreatic masses in the presence or the absence of chronic pancreatitis. Gastrointest Endosc. 2005;62:728–736.
Ardengh JC, Lopes CV, Campos AD, et al. Endoscopic ultrasound and fine needle aspiration in chronic pancreatitis: differential diagnosis between pseudotumoral masses and pancreatic cancer. JOP. 2007;8:413–421.
Hocke M, Schulze E, Gottschalk P, et al. Contrast-enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer. World J Gastroenterol. 2006;12:246–250.
Kitano M, Sakamoto H, Matsui U, et al. A novel perfusion imaging technique of the pancreas: Contrast-enhanced harmonic EUS (with video). Gastrointest Endosc. 2008, 67, 141–150.
Zhang, B.; Zhu, F.; Li, P.; Yu, S.; Zhao, Y.; Li, M. Endoscopic ultrasound elastography in the diagnosis of pancreatic masses: A meta-analysis. Pancreatology 2018, 18, 833–840.
Frossard JL, Amouyal P, Amouyal G, et al. Performance of endosonography-guided fine needle aspiration and biopsy in the diagnosis of pancreatic cystic lesions. Am J Gastroenterol 2003;98:1516.
Jones EC, Suen KC, Grant DR, et al. Fine-needle aspiration cytology of neoplastic cysts of the pancreas. Diagn Cytopathol. 1987;3:238.
Centeno BA, Lewandrowski KB, Warshaw AL, et al. Cyst fluid cytologic analysis in the differential diagnosis of pancreatic cystic lesions. Am J Clin Pathol. 1994;101:483.
Khalid A, Brugge W. ACG practice guidelines for the diagnosis and management of neoplastic pancreatic cysts. Am J Gastroenterol 2007;102:2339.
Cellier C, Cuillerier E, Palazzo L, et al. Intraductal papillary and mucinous tumors of the pancreas: accuracy of preoperative computed tomography, endoscopic retrograde pancreatography and endoscopic ultrasonography, and long-term outcome in a large surgical series. Gastrointest Endosc 1998;47:42.
Sugiyama M, Atomi Y, Saito M. Intraductal papillary tumors of the pancreas: evaluation with endoscopic ultrasonography. Gastrointest Endosc.1998;48:164.
Pais SA, Attasaranya S, Leblanc JK, et al. Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: correlation with surgical histopathology. Clin Gastroenterol Hepatol. 2007;5:489.
Tanno S, Nakano Y, Nishikawa T, et al. Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results. Gut. 2008;57:339.
Kim KW, Park SH, Pyo J, et al. Imaging features to distinguish malignant and benign branch-duct type intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis. Ann Surg. 2014;259:72
Grützmann R, Niedergethmann M, Pilarsky C, et al. Intraductal papillary mucinous tumors of the pancreas: biology, diagnosis, and treatment. Oncologist. 2010;15:1294
Fasanella KE, McGrath K. Cystic lesions and intraductal neoplasms of the pancreas. Best Pract Res Clin Gastroenterol 2009;23:35.
Bardales RH, Centeno B, Mallery JS, et al. Endoscopic ultrasound-guided fine-needle aspiration cytology diagnosis of solid-pseudopapillary tumor of the pancreas: a rare neoplasm of elusive origin but characteristic cytomorphologic features. Am J Clin Pathol. 2004;121:654.
Yamaguchi T, Shirai Y, Nakamura N, et al. Usefulness of Brush Cytology Combined with Pancreatic Juice Cytology in the Diagnosis of Pancreatic Cancer. Pancreas. 2012;41:1225–1229.
Li H, Hu Z, Chen J, et al. Comparison of ERCP, EUS, and ERCP combined with EUS in diagnosing pancreatic neoplasms: A systematic review and meta-analysis. Tumor Biol. 2014;35:8867–8874.
Loperfido S, Angelini G, Benedetti G, et al. Major early complications from diagnostic and therapeutic ERCP: A prospective multicenter study. Gastrointest Endosc. 1998;48:1–10.
Cheng CL, Sherman S, Watkins JL, et al. Risk Factors for Post-ERCP Pancreatitis: A Prospective Multicenter Study. Am J Gastroenterol. 2006;101:139–147.
Maire F, Couvelard A, Hammel P, et al. Intraductal papillary mucinous tumors of the pancreas: the preoperative value of cytologic and histopathologic diagnosis. Gastrointest Endosc. 2003;58:701-706.
